Zeitschrift für Parasitenkunde

, Volume 60, Issue 1, pp 3–17 | Cite as

Recent advances in applied malaria immunology

  • Clarence A. Speer
  • Paul H. Silverman
Review

Summary

Our present knowledge of cellular and humoral factors which are involved in immunity to plasmodial infections are discussed. Immunization against plasmodial infection has been achieved in birds, rodents, simians, and humans. Avian hosts have been immunized against gametocytes which resulted in inhibition of gametocytes within the mosquito vector. Immunization of humans against plasmodial gametocytes would indirectly protect them against malaria by blocking mosquito transmission to other susceptible individuals. Immunization by sporozoites provides short-lived protection against sporozoite challenge, but gives no protection against erythrocytic forms. Some success has been obtained in immunizing avian and mammalian hosts with exoerythrocytic forms obtained from cultured avian cells. The most significant advances have occurred in immunizing simian hosts against simian or human malaria by vaccinating with fresh erythrocytic merozoites or a nonviable lyophilized antigen obtained from intraerythrocytic forms.

The development of an antigen preparation suitable for use as a human malaria vaccine is dependent upon prior development of an in vitro system which would provide adequate amounts of parasite material. Efforts to cultivate the sporogonic, exoerythrocytic, and erythrocytic phases of plasmodia as well as the feasibility of using these forms for vaccination are discussed.

Keywords

Malaria Plasmodium Malaria Vaccine Plasmodial Infection Human Malaria 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Atkinson, J.P., Glen, R.H., Neva, F.A., Frank, M.M.: Serum complement and immunity in experimental simian malaria. II. Preferential activation of early components and failure of depletion of late components to inhibit protective immunity. J. Infect. Dis.131, 26–33 (1975)CrossRefPubMedGoogle Scholar
  2. Ball, G.H.: In vitro culture of the mosquito phase of avian malaria. J. Parasitol.50, 3–10 (1964)PubMedGoogle Scholar
  3. Ball, G.H., Chao, J.: The cultivation ofPlasmodium relictum in mosquito cell lines. J. Parasitol.57, 391–395 (1971)CrossRefPubMedGoogle Scholar
  4. Barker, L.R.: Experimental malaria: Effects upon the immune response to different antigens. J. Infect. Dis.123, 99–101 (1971)CrossRefPubMedGoogle Scholar
  5. Beaudoin, R.L., Strome, C.P.A., Clutter, W.G.: A tissue culture system for the study of drug action against the tissue phase of malaria. Milit. Med.134, 979–985 (1969)Google Scholar
  6. Beaudoin, R.L., Strome, C.P.A., Clutter, W.G.: Cultivation of avian malaria parasites in mammalian liver cells. Exp. Parasitol.36, 355–359 (1974)CrossRefPubMedGoogle Scholar
  7. Beaudoin, R.L., Strome, C.P.A., Mitchell, F., Tubergen, T.A.:Plasmodium berghei: Immunization of mice against the ANKA strain using the unaltered sporozoite as an antigen. Exp. Parasitol.42, 1–5 (1977)CrossRefPubMedGoogle Scholar
  8. Beckwith, R., Schenkel, R.H., Silverman, P.H.: Qualitative analysis of phospholipids isolated from nonviable plasmodium antigen. Exp. Parasitol.37, 164–172 (1975)CrossRefPubMedGoogle Scholar
  9. Brown, K.N.: Mechanisms of survival. In: Parasites in the immunized host. Ciba Foundation Symposium, pp. 35–71. New York: Elsevier 1974Google Scholar
  10. Brown, I.N., Allison, A.C., Taylor, R.B.:Plasmodium berghei infection in thymectomized rats. Nature219, 292–293 (1968)CrossRefPubMedGoogle Scholar
  11. Brown, K.N., Brown, I.N.: Immunity to malaria: Antigenic variation in chronic infections inPlasmodium knowlesi. Nature208, 1286–1288 (1965)CrossRefPubMedGoogle Scholar
  12. Brown, K.N., Brown, I.N., Hills, L.A.: Immunity to malaria. I. Protection againstPlasmodium knowlesi shown by monkeys sensitized with drug-suppressed infections or by dead parasites in Freund's adjuvant. Exp. Parasitol.28, 304–317 (1970)CrossRefPubMedGoogle Scholar
  13. Butcher, G.A., Cohen, S.: Antigenic variation and protective immunity inPlasmodium knowlesi malaria. Immunology23, 503–521 (1972)PubMedPubMedCentralGoogle Scholar
  14. Cabrera, E.J., Alger, N.E.: Transfer of adoptive immunity ofPlasmodium berghei: A comparison of routes of infection. J. Protozool.18, 596–597 (1971)CrossRefPubMedGoogle Scholar
  15. Cabrera, E.J., Barr, M.L., Silverman, P.H.: Long-term studies on rhesus monkeys (Macaca mulatta) immunized againstPlasmodium knowlesi. Infect. Immun.15, 451–455 (1977)Google Scholar
  16. Cabrera, E.J., Speer, C.A., Schenkel, R.H., Barr, M.C., Silverman, P.H.: Delayed dermal hypersensitivity in rhesus monkey (Macaca mulatta) immunized againstPlasmodium knowlesi. Z. Parasitenkd.50, 31–42 (1976)CrossRefPubMedGoogle Scholar
  17. Carter, R., Chen, D.H.: Malaria transmission blocked by immunization with gametes of the malaria parasite. Nature263, 57–60 (1976)CrossRefPubMedGoogle Scholar
  18. Chao, J., Ball, G.H.: Cultivation of the insect cycle of plasmodia. Am. J. Trop. Med. Hyg.13, 181–192 (1964)Google Scholar
  19. Clark, I.A., Allison, A.C., Cox, F.E.: Protection of mice againstBabesia andPlasmodia with BCG. Nature259, 309–311 (1976)CrossRefPubMedGoogle Scholar
  20. Clyde, D.F., McCarthy, V.C., Miller, R.N., Hormick, R.B.: Specificity of protection of man immunized against sporozoite-induced falciparum malaria. Am. J. Med. Sci.266, 398–340 (1973a)CrossRefPubMedGoogle Scholar
  21. Clyde, D.F., McCarthy, V.C., Miller, R.N., Woodward, W.E.: Immunization of man against sporozoite-induced falciparum malaria. Am. J. trop. Med. Hyg.24, 391–401 (1975)Google Scholar
  22. Clyde, D.F., Most, H., McCarthy, V.C., Vanderberg, J.P.: Immunization of man against sporozoitedinduced falciparum malaria. Am. J. Med. Sci.266, 169–177 (1973b)CrossRefPubMedGoogle Scholar
  23. Cohen, S., Butcher, G.A.: Serum antibody in acquired malarial immunity. Trans. R. Soc. Trop. Med. Hyg.65, 125–135 (1971)CrossRefPubMedGoogle Scholar
  24. Cohen, S., Butcher, G.A., Crandall, R.B.: Action of malarial antibody in vitro. Nature223, 368–371 (1969)CrossRefPubMedGoogle Scholar
  25. Cohen, S., Butcher, G.A., Mitchell, G.H.: Mechanisms of immunity to malaria. Bull. WHO50, 251–257 (1974)PubMedPubMedCentralGoogle Scholar
  26. Cohen, S., McGregor, J.A., Carrington, S.P.: Gamma globulin and acquired immunity to human malaria. Nature129, 733–737 (1961)CrossRefGoogle Scholar
  27. Coggeshall, L.T., Kumm, H.W.: Demonstration of passive immunity in experimental monkey malaria. J. Exp. Med.66, 177–190 (1937)CrossRefPubMedPubMedCentralGoogle Scholar
  28. Collins, W.E., Contacos, P.G., Harrison, A.J., Stanfill, P.S., Skinner, J.C.: Attempts to immunize monkeys againstPlasmodium knowlesi by using heat-stable serum-soluble antigens. Am. J. Trop. Med. Hyg.26, 373–376 (1977)PubMedGoogle Scholar
  29. Corradetti, A.: Prospects for vaccination against human malaria. Bull. WHO50, 287–291 (1974)PubMedPubMedCentralGoogle Scholar
  30. Cox, F.E.G., Belkey, D.L.J., Nicol, T.: Reticulo-endothelial activity in mice infected withPlasmodium vinckei. J. Protozool.11, 229–236 (1964)CrossRefPubMedGoogle Scholar
  31. Davis, A.G., Hufford, C.G., Palmer, T.T.: Procedures for maximum production of exoerythrocytic stages ofPlasmodium fallax in tissue culture. Exp. Parasitol.19, 1–8 (1966)CrossRefPubMedGoogle Scholar
  32. Diggs, C.L., Osler, A.G.: Humoral immunity in rodent malaria. II. Inhibition of parasitemia by serum antibody. J. Immunol.102, 298–305 (1969)PubMedGoogle Scholar
  33. Diggs, C.L., Osler, A.G.: Humoral immunity in rodent malaria. III. Studies on the site of antibody action. J. Immunol.114, 1243–1247 (1975)PubMedGoogle Scholar
  34. Diggs, C.L., Shin, H., Briggs, N.T., Laudenslayer, K., Weber, R.: Antibody mediated immunity toPlasmodium berghei independent of the third component of complement. Proc. Helminthol. Soc. Wash.39 (special issue), 449–459 (1972a)Google Scholar
  35. Diggs, C.L., Wellde, B.T., Anderson, J.S., Weber, R.M., Rodriquez, E., Jr.: The protective effect of African human immunoglobulin G inAotus trivirgatus infected with AsianPlasmodium falciparum. Proc. Helminthol. Soc. Wash.39 (special issue), 449–456 (1972a)Google Scholar
  36. Eaton, M.D.: The agglutination ofPlasmodium knowlesi by immune serum. J. Exp. Med.67, 857–870 (1938)CrossRefPubMedPubMedCentralGoogle Scholar
  37. Eisen, H., Furusawa, M., Tanabe, K., Takada, S., Ostertag, W.: Interactions of rodent malarial parasites with Friend erythroleukemia cells in vitro. Bull. WHO55, 367–372 (1977)PubMedPubMedCentralGoogle Scholar
  38. Finerty, J.F., Krehl, E.P.: Delayed immune reactions in mice immunized with malaria antigen. Am. J. Trop. Med. Hyg.26, 377–388 (1977)PubMedGoogle Scholar
  39. Gopalan, C.: Annual report of director-general. Indian Council Med. Res., New Delhi: Leipzig Press 1976Google Scholar
  40. Gravely, S.M., Kreier, J.P.: Adoptive transfer of immunity toPlasmodium berghei with immune T and B lymphocytes. Infect Immun.14, 184–190 (1976)PubMedPubMedCentralGoogle Scholar
  41. Greenwood, B.M.: Immunosuppression in malaria and trypanosomiasis. In: Parasites in the immunized host: Mechanisms of survival, pp. 137–146. Ciba Foundation Symposium, New York: Elsevier 1974Google Scholar
  42. Greenwood, B.M., Bradley-Moore, A.M., Palit, A., Bryceson, A.D.M.: Immunosuppression in children with malaria. Lancet1, 169–172 (1972)CrossRefPubMedGoogle Scholar
  43. Greenwood, B.M., Brown, J.C., DeJesus, D.G., Holborow, E.J.: Immunosuppression in murine malaria. III. The effect on reticuloendothelial and germinal center function. Clin. Exp. Immunol.9, 345–354 (1971a)PubMedPubMedCentralGoogle Scholar
  44. Greenwood, B.M., Playfair, J.H.L., Torrigiani, G.: Immunosuppression in murine malaria. I. General characteristics. Clin. Exp. Immunol.8, 467–478 (1971b)PubMedPubMedCentralGoogle Scholar
  45. Gwadz, R.W.: Malaria: Successful immunization against the sexual stages ofPlasmodium gallinaceum. Science193, 1150–1151 (1976)CrossRefPubMedGoogle Scholar
  46. Hilleman, M.R., Woodhour, A.F., Friedman, A., Phelps, A.H.: Studies on safety of adjuvant 65. Ann. Allergy30, 477–483 (1972)PubMedGoogle Scholar
  47. Holbrook, T.W., Palczuk, N.C., Stauber, L.A.: Immunity to exoerythrocytic forms of malaria. III. Stage-specific immunization of turkeys against exoerythrocytic forms ofPlasmodium fallax. J. Parasitol.60, 348–354 (1974)CrossRefPubMedGoogle Scholar
  48. Holbrook, T.W., Spitalny, G.L., Palczuk, N.C.: Stimulation of resistance in mice to sporozoiteinducedPlasmodium berghei malaria by infections of avian exoerythrocytic forms. J. Parasitol.62, 670–675 (1976)CrossRefPubMedGoogle Scholar
  49. Johnson, D.R.: Recent advances in mosquito-borne diseases: Malaria. Mosquito News33, 341–347 (1973)Google Scholar
  50. Kilejian, A., Abati, A., Trager, W.:Plasmodium falciparum andPlasmodium coatneyi: Immunogenicity of knob-like protrusions of infected erythrocyte membranes. Exp. Parasitol.42, 157–164 (1977)CrossRefPubMedGoogle Scholar
  51. Kitchen, A.G., DiLuzio, N.R.: Influence ofPlasmodium berghei infections on phagocytic and humoral recognition factor activity. J. Reticuloendothel. Soc.9, 237–247 (1971)PubMedGoogle Scholar
  52. Krettli, A., Chen, D.H., Nussenzweig, R.S.: Immunogenicity and infectivity of sporozoites of mammalian malaria isolated by density-gradient centrifugation. J. Protozool.20, 662–665 (1973)CrossRefPubMedGoogle Scholar
  53. Loose, L.D., Cook, J.A., DiLuzio, N.R.: Malarial immunosuppression—a macrophage mediated defect. Proc. Helminthol. Soc. Wash.39 (special issue), 484–491 (1972)Google Scholar
  54. Lucia, H.L., Nussenzweig, R.S.:Plasmodium chabaudi andPlasmodium vinckei: Phagocytic activity of the mouse reticuloendothelial system. Exp. Parasitol.25, 319–323 (1969)CrossRefPubMedGoogle Scholar
  55. McGregor, I.A., Carrington, S.P., Cohen, S.: Treatment of East AfricanPlasmodium falciparum malaria with West African human gamma-globulin. Trans. R. Soc. Trop. Med. Hyg.57, 170–175 (1963)CrossRefGoogle Scholar
  56. Miller, L.H., Aikawa, M., Dvorak, J.A.: Malaria (P. knowlesi) merozoites: Immunity and the surface coat. J. Immunol.114, 1237–1242 (1975)PubMedGoogle Scholar
  57. Mitchell, G.H., Butcher, G.A., Cohen, S.: A merozoite vaccine effective againstPlasmodium knowlesi malaria. Nature252, 311–313 (1974)CrossRefPubMedGoogle Scholar
  58. Mitchell, G.H., Butcher, G.A., Cohen, S.: Merozoite vaccination againstPlasmodium knowlesi malaria. Immunology29, 397–407 (1975)PubMedPubMedCentralGoogle Scholar
  59. Neiburger, R.G., Youmans, G.P., Youmans, A.S.: Relationship between tuberculin hypersensitivity and cellular immunity to infection in mice vaccinated with viable attenuated mycobacterial cells or with mycobacterial ribonucleic acid preparations. Infect. Immun.8, 42–47 (1973)PubMedPubMedCentralGoogle Scholar
  60. Nussenzweig, R.S.: Workshop on problems related to the development of an antimalaria vaccine, pp. 58–59, Washington: National Research Council 1974Google Scholar
  61. Nussenzweig, R.S., Chen, D.H.: The antibody response to sporozoites of simian and human malaria parasites: Its stage and species specificity and strain cross-reactivity. Bull. WHO50, 293–297 (1974)PubMedPubMedCentralGoogle Scholar
  62. Nussenzweig, R.S., Vanderberg, J.P., Most, H., Orton, C.: Protective immunity produced by the infection of x-irradiated sporozoites ofPlasmodium berghei. Nature216, 160–162 (1967)CrossRefPubMedGoogle Scholar
  63. Nussenzweig, R.S., Vanderberg, J.P., Sanobria, Y., Most, H.:Plasmodium berghei: Accelerated clearance of sporozoites from blood as part of immune-mechanism in mice. Exp. Parasitol.31, 88–97 (1972a)CrossRefPubMedGoogle Scholar
  64. Nussenzweig, R.S., Vanderberg, J., Spitalny, G.L., Rivera, C.I.O., Orton, C., Most, H.: Sporozoiteinduced immunity in mammalian malaria. Am. J. Trop. Med. Hyg.21, 722–728 (1972b)PubMedGoogle Scholar
  65. Phillips, R.S.:Plasmodium berghei: Passive transfer of immunity by antisera and cells. Exp. Parasitol.27, 479–495 (1970)CrossRefPubMedGoogle Scholar
  66. Rieckmann, K.H., Carson, P.E., Beaudoin, R.L., Cassells, J.S., Sell, K.W.: Sporozoite induced immunity in man against an Ethiopian strain ofPlasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg.68, 258–259 (1974)CrossRefPubMedGoogle Scholar
  67. Rieckmann, K.H., Mrema, J.E., Campbell, G.H.: Malaria immunity induced by infection with cultured parasites ofPlasmodium falciparum. J. Parasitol.64, 750–752 (1978)CrossRefPubMedGoogle Scholar
  68. Roberts, J.A., Tracey-Patte, P.J.: Adoptive transfer of immunity ofPlasmodium berghei. J. Protozool.16, 728–730 (1969)CrossRefPubMedGoogle Scholar
  69. Rosales-Ronquillo, M.C., Nienaber, G., Silverman, P.H.:Plasmodium berghei ookinete formation in a nonvector cell line. J. Parasitol.60, 1039–1040 (1974)CrossRefPubMedGoogle Scholar
  70. Rosales-Ronquillo, M.C., Silverman, P.H.: In vitro ookinete development of the rodent malaria parasite.Plasmodium knowlesi by use of a nonviable antigen. Bull. WHO48, 597–604 (1973)Google Scholar
  71. Schenkel, R.H., Cabrera, E.J., Barr, M.L., Silverman, P.H.: A new adjuvant for use in vaccination against malaria. J. Parasitol.61, 549–550 (1975)CrossRefGoogle Scholar
  72. Schneider, I.: Cultivation in vitro ofPlasmodium gallinaceum oocysts. Exp. Parasitol.22, 178–186 (1968)CrossRefPubMedGoogle Scholar
  73. Schneider, I.: A comparative study of the development of the mosquito cycle ofPlasmodium cynomolgi in primary cultures versus an established cell line ofAnopheles stephensi. Proc. Helminthol. Soc. Wash.39, (special issue), 438–444 (1972)Google Scholar
  74. Siddiqui, W.A.: An effective immunization of experimental monkeys against a human malaria parasite,Plasmodium falciparum. Science197, 388–389 (1977)CrossRefPubMedGoogle Scholar
  75. Simpson, G.L., Schenkel, R.H., Silverman, P.H.: Vaccination of rhesus monkeys against malaria by use of sucrose density gradient fractions ofPlasmodium knowlesi antigen. Nature247, 304–305 (1974)CrossRefPubMedGoogle Scholar
  76. Smith, R.A., Bigley, N.J.: Detection of delayed hypersensitivity in mice infected with ribonucleic acid-protein fractions ofSalmonella typhimurium. Infect. Immun.6, 384–389 (1972)PubMedPubMedCentralGoogle Scholar
  77. Speer, C.A., Silverman, P.H., Barr, M.L.: Ultrastructural study ofPlasmodium knowlesi antigen used in vaccination of rhesus monkeys. J. Protozool.23, 437–442 (1976a)CrossRefPubMedGoogle Scholar
  78. Speer, C.A., Silverman, P.H., Schiewe, S.G.: Cultivation of the erythrocytic stages ofPlasmodium berghei in Leydig cell tumor cultures. Z. Parasitenkd.50, 237–244 (1976b)CrossRefPubMedGoogle Scholar
  79. Speer, C.A., Silverman, P.H., Schiewe, S.G.: Cultivation of the erythrocytic stages ofPlasmodium berghei in primary bone marrow cells. J. Parasitol.62, 657–663 (1976c)CrossRefPubMedGoogle Scholar
  80. Spira, D.T., Silverman, P.H., Gaines, C.: Anti-thymocyte serum effects onPlasmodium berghei in rats. Immunology19, 759–766 (1970)PubMedPubMedCentralGoogle Scholar
  81. Spitalny, G.L., Nussenzweig, R.S.: Effect of various routes of immunization and methods of parasite attenuation on the development of protection against sporozoite-induced rodent malaria. Proc. Helminthol. Soc. Wash.39 (special issue), 506–514 (1972)Google Scholar
  82. Spitalny, G.L., Nussenzweig, R.S.:Plasmodium berghei: Relationship between protective immunity and antisporozoite (CSP) antibody in mice. Exp. Parasitol.33, 168–178 (1973)CrossRefPubMedGoogle Scholar
  83. Stechschulte, D.J.:Plasmodium berghei infection in thymectomized rats. Proc. Soc. Exp. Biol. Med.131, 748–752 (1969a)CrossRefPubMedGoogle Scholar
  84. Stechschulte, D.J.: Cell-mediated immunity in rats infected withPlasmodium berghei. Milit. Med.134, 1147–1152 (1969b)Google Scholar
  85. Trager, W.: Prolonged cultivation of malaria parasites (Plasmodium coatneyi andP. falciparum). In: Biochemistry of parasites and host-parasite relationships, van den Bossche, H. ed., pp. 427–434. Amsterdam: North-Holland Publishing Co. 1976Google Scholar
  86. Trager, W.:Plasmodium falciparum in culture: Improved continuous flow method. J. Protozool.26, 125–129 (1979)CrossRefPubMedGoogle Scholar
  87. Trager, W., Jensen, J.B.: Human malaria parasites in continuous culture. Science193, 673–675 (1976)CrossRefPubMedGoogle Scholar
  88. Vanderberg, J.P.: Inactivity of rodent malaria anti-sporozoite antibodies against exoerythrocytic forms. Am. J. Trop. Med. Hyg.22, 573–577 (1973)PubMedGoogle Scholar
  89. Vanderberg, J.P.: Development of infectivity by thePlasmodium berghei sporozoite. J. Parasitol.61, 43–50 (1975)CrossRefPubMedGoogle Scholar
  90. Vanderberg, J.P., Nussenzweig, R.S., Sanabria, Y., Nawrot, R., Most, H.: Stage specificity of anti-sporozoite antibodies in rodent malaria and its relationship to protective immunity. Proc. Helminthol. Soc. Wash.39 (special issue), 514–525 (1972)Google Scholar
  91. Voller, A.: Variant specific schizont agglutinating antibodies in human malaria (Plasmodium falciparum) infections inAotus. Trans. R. Soc. Trop. Med. Hyg.65, 2–3 (1971)CrossRefPubMedGoogle Scholar
  92. Waymouth, C., Chen, H.W., Wood, B.G.: Characteristics of mouse liver parenchymal cells in chemically defined media. In vitro6, 371 (1971)CrossRefGoogle Scholar
  93. Wells, R.A., Martin, L.K., Stutz, D.R., Diggs, C.L.:Plasmodium yoellii: An inbred model for protective immunization against malaria in BALB/c mice. Exp. Parasitol.41, 472–479 (1977)CrossRefPubMedGoogle Scholar
  94. WHO Tech. Dev. Series No. 579. Developments in malaria immunology. Geneva 1975Google Scholar
  95. WHO Special program for research and training in tropical diseases. No. 76.6. Malaria. Geneva 1976Google Scholar
  96. Young, M.D., Baerg, D.C., Rossan, R.N.: Studies with induced malarias inAotus monkeys. Lab. Anim. Sci.26, 1131–1137 (1976)PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1979

Authors and Affiliations

  • Clarence A. Speer
    • 1
  • Paul H. Silverman
    • 1
  1. 1.Department of MicrobiologyUniversity of MontanaMissoulaUSA

Personalised recommendations